Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey

Alfredo J Mena Lora; Rodrigo Burgos; Scott Borgetti; Lelia H Chaisson; Susan C Bleasdale

doi:10.1017/ash.2023.146

Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey

Antimicrob Steward Healthc Epidemiol. 2023 Mar 31;3(1):e63. doi: 10.1017/ash.2023.146. eCollection 2023.

Authors

Alfredo J Mena Lora¹, Rodrigo Burgos¹, Scott Borgetti¹, Lelia H Chaisson¹, Susan C Bleasdale¹

Affiliation

¹ University of Illinois at Chicago, Chicago, Illinois.

Abstract

Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with remdesivir restrictions were more guideline concordant. Formulary restrictions can be important for pandemic response.